FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mats Rudling

Research Profile

Chemicals & Drugs

Anatomy

Livers

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Roland Klingenberg; Christine Lohmann; Anna M Lundberg; Thomas F Lüscher; Stefan K Nilsson; Gunilla Olivecrona; Mats Rudling; Tim Sparwasser; Daniela Strodthoff; Stefan Zoller; Robert M Badeau; Norbert Gerdes; Anton Gisterå; Matti Jauhiainen; Daniel F J Ketelhuth; Göran K Hansson
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.
Helena Bjermo; Tommy Cederholm; Ingrid Dahlman; David Iggman; Lars Johansson; Joel Kullberg; Lena Persson; Kari Pulkki; Håkan Ahlström; Peter Arner; Samar Basu; Johan Berglund; Mats Rudling; Matti Uusitupa; Ulf Risérus
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.
Lena Persson; Bo Angelin; Peter Henriksson; Outi Hovatta; Eli Westerlund; Mats Rudling
Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mats Rudling (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roland Klingenberg; Christine Lohmann; Anna M Lundberg; Thomas F Lüscher; Stefan K Nilsson; Gunilla Olivecrona; Mats Rudling; Tim Sparwasser; Daniela Strodthoff; Stefan Zoller; Robert M Badeau; Norbert Gerdes; Anton Gisterå; Matti Jauhiainen; Daniel F J Ketelhuth; Göran K Hansson
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.
The Journal of clinical investigation 2013;123(3):1323-34.
2012: Helena Bjermo; Tommy Cederholm; Ingrid Dahlman; David Iggman; Lars Johansson; Joel Kullberg; Lena Persson; Kari Pulkki; Håkan Ahlström; Peter Arner; Samar Basu; Johan Berglund; Mats Rudling; Matti Uusitupa; Ulf Risérus
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.
The American journal of clinical nutrition 2012;95(5):1003-12.
2012: Lena Persson; Bo Angelin; Peter Henriksson; Outi Hovatta; Eli Westerlund; Mats Rudling
Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(3):810-4.
2012: Thomas Lundåsen; Johanna Lundberg; Eva-Marie Andersson; Bo Angelin; Helena Lindmark; Michael Snaith; Ann-Margret Östlund-Lindqvist; Mats Rudling
Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice.
PloS one 2012;7(5):e37787.
2011: Ivan Tancevski; Mats Rudling; Philipp Eller
Thyromimetics: a journey from bench to bed-side.
Pharmacology & therapeutics 2011;131(1):33-9.
2010: Bo Angelin; Mats Rudling
Lipid lowering with thyroid hormone and thyromimetics.
Current opinion in lipidology 2010;21(6):499-506.
2010: Lena Persson; Guoqing Cao; Lars Ståhle; Beatrice G Sjöberg; Jason S Troutt; Robert J Konrad; Cecilia Gälman; Håkan Wallén; Mats Eriksson; Ingiäld Hafström; Suzanne Lind; Maria Dahlin; Per Amark; Bo Angelin; Mats Rudling
Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(12):2666-72.
2010: Yuri Sheikine; Barbara Deodato; Peder S Olofsson; Leif A Söderström; Anna M Lundberg; Inger Bodin; Mats Rudling; Elvar Theodorsson; Göran K Hansson
Activation of VPAC1 receptors aggravates early atherosclerosis in hypercholesterolemic apolipoprotein E-deficient mice.
Biochemical and biophysical research communications 2010;402(3):471-6.
2010: Damir Zadravec; Annelie Brolinson; Rachel M Fisher; Claes Carneheim; Robert Csikasz; Justine Bertrand-Michel; Jan Borén; Hervé Guillou; Mats Rudling; Anders Jacobsson
Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(11):4366-77.
2010: Hanns-Ulrich Marschall; Despina Katsika; Mats Rudling; Curt Einarsson
The genetic background of gallstone formation: an update.
Biochemical and biophysical research communications 2010;396(1):58-62.
2010: Roland Klingenberg; Michael Lebens; Andreas Hermansson; Gunilla Nordin Fredrikson; Daniela Strodthoff; Mats Rudling; Daniel F J Ketelhuth; Norbert Gerdes; Jan Holmgren; Jan Nilsson; Göran K Hansson
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(5):946-52.
2010: Ivan Tancevski; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Hoefer; Christiane Heim; Ursula Stanzl; Andreas Wehinger; Kristina Auer; Regina Karer; Julia Huber; Wilfried Schgoer; Miranda Van Eck; Jonathan Vanhoutte; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice.
PloS one 2010;5(1):e8722.
2009: Olga Ovchinnikova; Asa Gylfe; Leslie Bailey; Anna Nordström; Mats Rudling; Christian Jung; Sven Bergström; Anders Waldenström; Göran K Hansson; Peter Nordström
Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1478-80.
2009: Ivan Tancevski; Andreas Wehinger; Egon Demetz; Julia Hoefer; Philipp Eller; Eva Huber; Ursula Stanzl; Kristina Duwensee; Kristina Auer; Wilfried Schgoer; Volker Kuhn; Catherine Fievet; Frans Stellaard; Mats Rudling; Bernhard Foeger; Josef R Patsch; Andreas Ritsch
The thyromimetic T-0681 protects from atherosclerosis.
Journal of lipid research 2009;50(5):938-44.
2009: Lena Persson; Cecilia Gälman; Bo Angelin; Mats Rudling
Importance of proprotein convertase subtilisin/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors.
Endocrinology 2009;150(3):1140-6.
2009: Kjell-Arne Ung; Nima Mottacki; Mats Rudling; Antal Bajor
Biliary sphincterotomy does not relate to diarrhoea or major changes in bile acid synthesis or plasma lipids.
Scandinavian journal of gastroenterology 2009;44(9):1132-8.
2008: Antal Bajor; Anders Kilander; Henrik Sjövall; Mats Rudling; Kjell-Arne Ung
The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time.
Digestive diseases and sciences 2008;53(11):2935-40.
2008: Cecilia Gälman; Tomas Lundåsen; Alexei Kharitonenkov; Holly A Bina; Mats Eriksson; Ingiäld Hafström; Maria Dahlin; Per Amark; Bo Angelin; Mats Rudling
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.
Cell metabolism 2008;8(2):169-74.
2008: Ivan Tancevski; Andreas Wehinger; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Huber; Kathrin Hochegger; Wilfried Schgoer; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.
Endocrinology 2008;149(7):3708-12.
2008: Paolo Parini; Ulf Gustafsson; Matt A Davis; Lilian Larsson; Curt Einarsson; Martha Wilson; Mats Rudling; Hiroshi Tomoda; Satoshi Omura; Staffan Sahlin; Bo Angelin; Lawrence L Rudel; Mats Eriksson
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(6):1200-6.
2008: Mats Rudling
Increased synthesis of bile acids in gallstone disease is a global finding and not a "peculiar condition" solely in Chile.
Hepatology (Baltimore, Md.) 2008;47(5):1796-7; author reply 1797-8.
2008: Cecilia Gälman; Ylva Bonde; Manuela Matasconi; Bo Angelin; Mats Rudling
Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone.
Gastroenterology 2008;134(4):1127-36.
2008: Peder S Olofsson; Leif A Söderström; Dick Wågsäter; Yuri Sheikine; Pauline Ocaya; François Lang; Catherine Rabu; Lieping Chen; Mats Rudling; Pål Aukrust; Ulf Hedin; Gabrielle Paulsson-Berne; Allan Sirsjö; Göran K Hansson
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
Circulation 2008;117(10):1292-301.
2008: Anders Berkenstam; Jens Kristensen; Karin Mellström; Bo Carlsson; Johan Malm; Stefan Rehnmark; Neeraj Garg; Carl Magnus Andersson; Mats Rudling; Folke Sjöberg; Bo Angelin; John D Baxter
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(2):663-7.
2007: Roland Klingenberg; Jerzy-Roch Nofer; Mats Rudling; Florian Bea; Erwin Blessing; Michael Preusch; Hermann J Grone; Hugo A Katus; Göran K Hansson; Thomas J Dengler
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(11):2392-9.
2007: Cecilia Gälman; Manuela Matasconi; Lena Persson; Paolo Parini; Bo Angelin; Mats Rudling
Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol.
American journal of physiology. Endocrinology and metabolism 2007;293(3):E737-42.
2007: Thomas Lundåsen; Mary C Hunt; Lisa-Mari Nilsson; Sabyasachi Sanyal; Bo Angelin; Stefan E H Alexson; Mats Rudling
PPARalpha is a key regulator of hepatic FGF21.
Biochemical and biophysical research communications 2007;360(2):437-40.
2007: Juan Castro; Ludwig Amigo; Juan Miquel; Cecilia Gälman; Fernando Crovari; Alejandro Raddatz; Silvana Zanlungo; Roberto Jalil; Mats Rudling; Flavio Nervi
Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease.
Hepatology (Baltimore, Md.) 2007;45(5):1261-6.
2006: Thomas Lundåsen; Cecilia Gälman; Bo Angelin; Mats Rudling
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
Journal of internal medicine 2006;260(6):530-6.
2006: Antal Bajor; Anders Kilander; Cecilia Gälman; Mats Rudling; Kjell-Arne Ung
Budesonide treatment is associated with increased bile acid absorption in collagenous colitis.
Alimentary pharmacology & therapeutics 2006;24(11-12):1643-9.
2006: Mats Rudling
[Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
Läkartidningen 2006;103(43):3278-82.
2006: Jin Wang; Mats Gåfvels; Mats Rudling; Charlotte Murphy; Ingemar Björkhem; Curt Einarsson; Gösta Eggertsen
Critical role of cholic acid for development of hypercholesterolemia and gallstones in diabetic mice.
Biochemical and biophysical research communications 2006;342(4):1382-8.
2006: Antal Bajor; Anders Kilander; Anita Fae; Cecilia Gälman; Olof Jonsson; Lena Ohman; Mats Rudling; Henrik Sjövall; Per-Ove Stotzer; Kjell-Arne Ung
Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption.
European journal of gastroenterology & hepatology 2006;18(4):397-403.
2006: Jacek Jawien; Mariusz Gajda; Mats Rudling; Lukasz Mateuszuk; Rafal Olszanecki; Tomasz Guzik; Tadeusz Cichocki; Stefan Chlopicki; Ryszard Korbut
Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice.
European journal of clinical investigation 2006;36(3):141-6.
2006: Paolo Parini; L Johansson; Anders Bröijersén; Bo Angelin; Mats Rudling
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system.
European journal of clinical investigation 2006;36(2):98-104.
2006: Jamila Khallou-Laschet; Emmanuel Tupin; giuseppina caligiuri; Bruno Poirier; Nathalie Thieblemont; Anh-Thu Gaston; Marta Vandaele; Jean Bleton; Alain Tchapla; Srini V Kaveri; Mats Rudling; Antonino Nicoletti
Atheroprotective effect of adjuvants in apolipoprotein E knockout mice.
Atherosclerosis 2006;184(2):330-41.
2005: Cecilia Gälman; Bo Angelin; Mats Rudling
Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis.
Gastroenterology 2005;129(5):1445-53.
2005: Manuela Matasconi; Paolo Parini; Bo Angelin; Mats Rudling
Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment.
Biochimica et biophysica acta 2005;1736(3):221-7.
2005: Lisen Johansson; Mats Rudling; Thomas S Scanlan; Thomas Lundåsen; Paul Webb; John Baxter; Bo Angelin; Paolo Parini
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(29):10297-302.
2005: Margaret E Brousseau; Margaret R Diffenderfer; John S Millar; Chorthip Nartsupha; Bela F Asztalos; Francine K Welty; Megan L Wolfe; Mats Rudling; Ingemar Björkhem; Bo Angelin; James P Mancuso; Andres G Digenio; Daniel J Rader; Ernst Schaefer
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(5):1057-64.
2005: Xinghua Zhou; Anna-Karin L Robertson; Mats Rudling; Paolo Parini; Göran K Hansson
Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Circulation research 2005;96(4):427-34.
2004: Suzanne Lind; Anders G Olsson; Mats Eriksson; Mats Rudling; Gösta Eggertsen; Bo Angelin
Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.
Journal of internal medicine 2004;256(5):406-12.
2004: Manuela Matasconi; Bo Angelin; Mats Rudling
Pituitary control of lipoprotein and bile acid metabolism in male rats: growth hormone effects are not mediated by prolactin.
American journal of physiology. Endocrinology and metabolism 2004;287(1):E114-9.
2004: Cecilia Gälman; Juan Miquel; Rosa Maria Pérez; Curt Einarsson; Lars Ståhle; Guillermo Marshall; Flavio Nervi; Mats Rudling
Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians.
Gastroenterology 2004;126(3):741-8.
2004: Emmanuel Tupin; Antonino Nicoletti; Rima Elhage; Mats Rudling; Hans-Gustaf Ljunggren; Göran K Hansson; Gabrielle Paulsson Berne
CD1d-dependent activation of NKT cells aggravates atherosclerosis.
The Journal of experimental medicine 2004;199(3):417-22.
2004: Suzanne Lind; Mats Rudling; Sverker Ericsson; Hans Olivecrona; Mats Eriksson; Birgit Borgström; Gösta Eggertsen; Lars Berglund; Bo Angelin
Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(2):349-56.
2004: Petra Tollet-Egnell; Paolo Parini; Nina Ståhlberg; Ingrid Lönnstedt; Norman H Lee; Mats Rudling; Amilcar Flores-Morales; Gunnar Norstedt
Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profiles.
Physiological genomics 2004;16(2):261-7.
2003: Anna-Karin L Robertson; Mats Rudling; Xinghua Zhou; Leonid Gorelik; Richard A Flavell; Göran K Hansson
Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.
The Journal of clinical investigation 2003;112(9):1342-50.
2003: Thomas Lundåsen; Wei Liao; Bo Angelin; Mats Rudling
Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice.
The Journal of biological chemistry 2003;278(44):43224-8.
2003: Rima Elhage; Jacek Jawien; Mats Rudling; Hans-Gustaf Ljunggren; Kiyoshi Takeda; Shizuo Akira; Francis Bayard; Göran K Hansson
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice.
Cardiovascular research 2003;59(1):234-40.
2003: Bethan Jones; Emma L Jones; Stephanie A Bonney; Hetal N Patel; Arjen Mensenkamp; Sophie Eichenbaum-Voline; Mats Rudling; Urban Myrdal; Grazia Annesi; Sandhia Naik; Nigel Meadows; Aldo Quattrone; Suhail A Islam; Rossi P Naoumova; Bo Angelin; Recaredo Infante; Emile Levy; Claude C Roy; Paul S Freemont; James Scott; Carol C Shoulders
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders.
Nature genetics 2003;34(1):29-31.
2003: Cecilia Gälman; Ingela Arvidsson; Bo Angelin; Mats Rudling
Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood.
Journal of lipid research 2003;44(4):859-66.
2003: Cecilia Gälman; Ann-Margret Ostlund-Lindqvist; Anna Björquist; Sandra Schreyer; Lennart Svensson; Bo Angelin; Mats Rudling
Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(2):265-7.
2003: giuseppina caligiuri; Mats Rudling; Véronique Ollivier; Marie-Paule Jacob; Jean-Baptiste Michel; Göran K Hansson; Antonino Nicoletti
Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.
Molecular medicine (Cambridge, Mass.) 2003;9(1-2):10-7.
2002: Mats Rudling; Bo Angelin; Lars Ståhle; Eva Reihnér; Staffan Sahlin; Hans Olivecrona; Ingemar Björkhem; Curt Einarsson
Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver.
The Journal of clinical endocrinology and metabolism 2002;87(9):4307-13.
2002: Hjalmar Gullberg; Mats Rudling; Carmen Saltó; Douglas Forrest; Bo Angelin; Björn Vennström
Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice.
Molecular endocrinology (Baltimore, Md.) 2002;16(8):1767-77.
2002: Ingemar Björkhem; Zufan Araya; Mats Rudling; Bo Angelin; Curt Einarsson; Kjell Wikvall
Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1.
The Journal of biological chemistry 2002;277(30):26804-7.
2002: CG Hillebrant; B Nyberg; Ulf Gustafsson; Staffan Sahlin; Ingemar Björkhem; Mats Rudling; Curt Einarsson
Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
European journal of clinical investigation 2002;32(7):528-34.
2002: Cecilia Gälman; Bo Angelin; Mats Rudling
Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol.
Endocrinology 2002;143(5):1809-16.
2002: Ville Wallenius; Kristina Wallenius; Bo Ahrén; Mats Rudling; Hans Carlsten; Suzanne Dickson; Claes Ohlsson; John-Olov Jansson
Interleukin-6-deficient mice develop mature-onset obesity.
Nature medicine 2002;8(1):75-9.
2001: Mats Rudling; Bo Angelin
Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(8):1350-6.
2001: Siegfried Alberti; Gertrud Schuster; Paolo Parini; D Feltkamp; Ulf Diczfalusy; Mats Rudling; Bo Angelin; Ingemar Björkhem; S Pettersson; Jan-�ke GUSTAFSSON
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.
The Journal of clinical investigation 2001;107(5):565-73.
2000: Claes Ohlsson; N Hellberg; Paolo Parini; ON Vidal; Mohammad Bohlooly-Y; M Bohlooly; Mats Rudling; Marie K Lindberg; M Warner; Bo Angelin; Jan-�ke GUSTAFSSON
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice.
Biochemical and biophysical research communications 2000;278(3):640-5.
2000: Hjalmar Gullberg; Mats Rudling; Douglas Forrest; Bo Angelin; Björn Vennström
Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol.
Molecular endocrinology (Baltimore, Md.) 2000;14(11):1739-49.
2000: Paolo Parini; Bo Angelin; A Stavréus-Evers; Bo Freyschuss; H Eriksson; Mats Rudling
Biphasic effects of the natural estrogen 17beta-estradiol on hepatic cholesterol metabolism in intact female rats.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1817-23.
1999: CG Hillebrant; B Nyberg; Bo Angelin; Magnus Axelson; Ingemar Björkhem; Mats Rudling; Curt Einarsson
Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.
Journal of internal medicine 1999;246(4):399-407.
1999: Bo Angelin; M Eriksson; Mats Rudling
Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era?
Current opinion in lipidology 1999;10(3):269-74.
1999: Mats Rudling; Paolo Parini; Bo Angelin
Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9 Suppl A():1-7.
1999: Paolo Parini; Bo Angelin; Mats Rudling
Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):832-9.
1998: Mats Rudling; Mats Gåfvels; Paolo Parini; G Gahrton; Bo Angelin
Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.
The American journal of pathology 1998;153(6):1923-35.
1998: Ewa Ellis; B Goodwin; Anna Abrahamsson; Christopher Liddle; A Mode; Mats Rudling; Ingemar Bjorkhem; Curt Einarsson
Bile acid synthesis in primary cultures of rat and human hepatocytes.
Hepatology (Baltimore, Md.) 1998;27(2):615-20.
1997: Paolo Parini; Bo Angelin; Mats Rudling
Importance of estrogen receptors in hepatic LDL receptor regulation.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(9):1800-5.
1997: D Ståhlberg; Mats Rudling; Bo Angelin; I Björkhem; P Forsell; K Nilsell; K Einarsson
Hepatic cholesterol metabolism in human obesity.
Hepatology (Baltimore, Md.) 1997;25(6):1447-50.
1997: Mats Rudling; Paolo Parini; Bo Angelin
Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.
The Journal of clinical investigation 1997;99(9):2239-45.
1997: W Liao; Mats Rudling; Bo Angelin
Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat.
Endocrinology 1997;138(5):1863-70.
1996: Mats Rudling; S Vitols; M Masquelier; Curt Peterson
Cryopreserve LDL in the presence of sucrose to protect the biologic properties.
Journal of lipid research 1996;37(10):2266-7.
1996: Mats Rudling; H Olivecrona; Gösta Eggertsen; Bo Angelin
Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.
The Journal of clinical investigation 1996;97(2):292-9.
1996: Mats Rudling; V P Collins
Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma.
Biochimica et biophysica acta 1996;1299(1):75-9.
1995: Paolo Parini; Bo Angelin; P E Lobie; G Norstedt; Mats Rudling
Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells.
Endocrinology 1995;136(9):3767-73.
1995: Dagny Ståhlberg; E Reihnér; Mats Rudling; Lars Berglund; K Einarsson; Bo Angelin
Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase.
Hepatology (Baltimore, Md.) 1995;21(4):1025-30.
1994: E Sudjana-Sugiaman; Gösta Eggertsen; P Sjöblom; Y Maeda; Mats Rudling; K Okuda; Ingemar Björkhem
Presence of cholesterol 7 alpha-hydroxylase enzyme protein in COS-cells leads to increased HMG CoA reductase activity.
Biochemical and biophysical research communications 1994;202(2):896-901.
1994: Bo Angelin; Mats Rudling
Growth hormone and hepatic lipoprotein metabolism.
Current opinion in lipidology 1994;5(3):160-5.
1993: Mats Rudling; Bo Angelin
Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(19):8851-5.
1993: Mats Rudling; Bo Angelin
Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo.
The Journal of clinical investigation 1993;91(6):2796-805.
1993: Bo Angelin; H Olivecrona; S Ericsson; Mats Rudling
Growth hormone and low-density lipoproteins.
Acta endocrinologica 1993;128 Suppl 2():26-8.
1992: Bo Angelin; H Olivecrona; E Reihnér; Mats Rudling; Dagny Ståhlberg; M Eriksson; S Ewerth; P Henriksson; K Einarsson
Hepatic cholesterol metabolism in estrogen-treated men.
Gastroenterology 1992;103(5):1657-63.
1992: Bo Angelin; Mats Rudling; H Olivecrona; S Ericsson
Effects of growth hormone on low-density lipoprotein metabolism.
Acta paediatrica (Oslo, Norway : 1992). Supplement 1992;383():67-8; discussion 69.
1992: Mats Rudling; G Norstedt; H Olivecrona; E Reihnér; J A Gustafsson; Bo Angelin
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):6983-7.
1992: Bo Angelin; Mats Rudling
Molecular aspects of human lipid metabolism.
European journal of clinical nutrition 1992;46(3):153-60.
1991: J E Akerlund; E Reihnér; Bo Angelin; Mats Rudling; S Ewerth; Ingemar Björkhem; K Einarsson
Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum.
Gastroenterology 1991;100(4):1046-53.
1991: E Reihnér; Mats Rudling; Dagny Ståhlberg; Lars Berglund; S Ewerth; I Björkhem; K Einarsson; B Angelin
[Effect of pravastatin on hepatic cholesterol metabolism].
Fortschritte der Medizin 1991;109(8):189-94.
1991: K Einarsson; S Ericsson; S Ewerth; E Reihnér; Mats Rudling; Dagny Ståhlberg; Bo Angelin
Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.
European journal of clinical pharmacology 1991;40 Suppl 1():S53-8.
1991: Curt Peterson; M Masquelier; Mats Rudling; K Söderberg; S Vitols
Lipoproteins, malignancy, and anticancer agents.
Targeted diagnosis and therapy 1991;5():175-200.
1990: E Reihnér; B Angelin; Mats Rudling; S Ewerth; I Björkhem; K Einarsson
Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
Journal of lipid research 1990;31(12):2219-26.
1990: E Reihnér; Mats Rudling; Dagny Ståhlberg; Lars Berglund; S Ewerth; I Björkhem; K Einarsson; B Angelin
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
The New England journal of medicine 1990;323(4):224-8.
1990: Mats Rudling; E Reihnér; K Einarsson; S Ewerth; B Angelin
Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(9):3469-73.
1990: S Vitols; Bo Angelin; S Ericsson; G Gahrton; G Juliusson; M Masquelier; C Paul; Curt Peterson; Mats Rudling; K Söderberg-Reid
Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(7):2598-602.
1990: Mats Rudling; Bo Angelin; C O Peterson; V P Collins
Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement.
Cancer research 1990;50(3):483-7.
1989: P Henriksson; M Eriksson; S Ericsson; Mats Rudling; R Stege; Lars Berglund; Bo Angelin
Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate.
Lancet 1989;2(8673):1178-80.
1989: M Eriksson; Lars Berglund; Mats Rudling; P Henriksson; Bo Angelin
Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma.
The Journal of clinical investigation 1989;84(3):802-10.
1987: B Angelin; E Reihnér; Mats Rudling; S Ewerth; I Björkhem; K Einarsson
In vitro studies of lipid metabolism in human liver.
American heart journal 1987;113(2 Pt 2):482-7.
1986: Mats Rudling; L Ståhle; C O Peterson; L Skoog
Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients.
British medical journal (Clinical research ed.) 1986;292(6520):580-2.
1985: Mats Rudling; C O Peterson
LDL receptors in bovine tissues assayed as the heparin-sensitive binding of 125I-labeled LDL in homogenates: relation between liver LDL receptors and serum cholesterol in the fetus and post term.
Biochimica et biophysica acta 1985;836(1):96-104.
1985: Mats Rudling; C O Peterson
A simple binding assay for the determination of low-density lipoprotein receptors in cell homogenates.
Biochimica et biophysica acta 1985;833(3):359-65.
1985: C Peterson; S Vitols; Mats Rudling; H Blomgren; F Edsmyr; L Skoog
Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells.
Medical oncology and tumor pharmacotherapy 1985;2(3):143-7.
1983: Mats Rudling; V P Collins; C O Peterson
Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway.
Cancer research 1983;43(10):4600-5.